Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives

Alberico Luigi Catapano,1,2 Angela Pirillo,1,2 Giuseppe Danilo Norata1,3,4 1Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 2IRCCS Multimedica Hospital, Sesto San Giovanni, 3Center for the Study of Atherosclerosis, E. Bassini Hospital, Cinisello...

Full description

Bibliographic Details
Main Authors: Catapano AL, Pirillo A, Norata GD
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:Vascular Health and Risk Management
Online Access:https://www.dovepress.com/anti-pcsk9-antibodies-for-the-treatment-of-heterozygous-familial-hyper-peer-reviewed-article-VHRM

Internet

https://www.dovepress.com/anti-pcsk9-antibodies-for-the-treatment-of-heterozygous-familial-hyper-peer-reviewed-article-VHRM

Similar Items